Study finds copper-based drug reduces toxic Alzheimer's proteins
Melbourne (ANTARA) - A team of researchers in Australia has found that a drug delivering copper to the brain can significantly reduce toxic Alzheimer’s proteins and improve long-term spatial memory in laboratory experiments.
The study shows that Cu(ATSM), a copper compound capable of penetrating the brain and helping to clear toxic proteins, can repair vital waste disposal pumps in the blood-brain barrier. This opens new avenues for treating neurovascular dysfunction caused by Alzheimer’s and other types of dementia, which are leading causes of death in Australia, according to a statement from Monash University Australia released on Monday (15/6).
In Alzheimer’s disease, this system, driven by the P-glycoprotein (P-gp) pump, becomes impaired, allowing toxic amyloid-beta proteins to accumulate in the brain, according to researchers.
The findings, published in ACS Chemical Neuroscience, provide a strong foundation for exploring biometal therapies, such as Cu(ATSM), to combat vascular dysfunction and memory loss in Alzheimer’s disease.
The study’s lead author, Jae Pyun, a lecturer at the Monash Institute of Pharmaceutical Sciences (MIPS), stated that the treatment successfully engaged the brain’s blood vessels to lower toxic protein levels, resulting in positive behavioural effects.
The study showed that Cu(ATSM) increased P-gp levels by 24.1 per cent in Alzheimer’s models, “effectively linking blood-brain barrier repair with reduced toxic proteins and improved cognitive function,” said Pyun.
“By enhancing the function of this pump, the brain can finally clear trapped waste. Over 56 days, the treatment reduced toxic amyloid-beta by approximately 42 per cent and improved spatial learning by nearly 44 per cent,” he added.
Senior author Professor Joseph Nicolazzo from MIPS stated that Cu(ATSM), a copper compound possessing anti-inflammatory and neuroprotective properties, has been safely tested in clinical trials for Parkinson’s and ALS, potentially accelerating the progression towards human studies for Alzheimer’s disease.
Source: jawawa.id (https://jawawa.id/newsitem/study-finds-copper-based-drug-reduces-toxic-alzheimers-proteins-1781524400)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5609080/studi-temukan-obat-berbasis-tembaga-kurangi-protein-beracun-alzheimer), translated from Indonesian